Credit Suisse’s BioMarin Pharmaceuticals BMRN Stock Holding History

Credit Suisse’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	$25M	Sell	286,650 -25,343	-8%	-$2.21M	0.02%	568
2023 Q4	$30.1M	Sell	311,993 -25,672	-8%	-$2.48M	0.03%	535
2023 Q3	$29.9M	Sell	337,665 -6,009	-2%	-$532K	0.03%	522
2023 Q2	$29.8M	Sell	343,674 -155,123	-31%	-$13.4M	0.03%	541
2023 Q1	$48.5M	Sell	498,797 -8,355	-2%	-$812K	0.05%	404
2022 Q4	$52.5M	Buy	507,152 +24,331	+5%	+$2.52M	0.06%	369
2022 Q3	$40.9M	Buy	482,821 +47,534	+11%	+$4.03M	0.05%	428
2022 Q2	$36.1M	Sell	435,287 -82,125	-16%	-$6.81M	0.04%	490
2022 Q1	$39.9M	Buy	517,412 +10,418	+2%	+$803K	0.03%	526
2021 Q4	$44.8M	Sell	506,994 -40,528	-7%	-$3.58M	0.02%	509
2021 Q3	$42.3M	Sell	547,522 -39,839	-7%	-$3.08M	0.02%	521
2021 Q2	$49M	Buy	587,361 +6,627	+1%	+$553K	0.03%	516
2021 Q1	$43.9M	Buy	580,734 +9,679	+2%	+$731K	0.02%	570
2020 Q4	$50.1M	Buy	571,055 +118,701	+26%	+$10.4M	0.02%	509
2020 Q3	$34.4M	Buy	452,354 +17,642	+4%	+$1.34M	0.02%	555
2020 Q2	$53.6M	Buy	434,712 +169,051	+64%	+$20.9M	0.04%	399
2020 Q1	$22.4M	Sell	265,661 -52,195	-16%	-$4.41M	0.02%	622
2019 Q4	$26.9M	Buy	317,856 +13,837	+5%	+$1.17M	0.02%	650
2019 Q3	$20.5M	Buy	304,019 +11,258	+4%	+$759K	0.02%	682
2019 Q2	$25.1M	Buy	292,761 +24,679	+9%	+$2.11M	0.02%	613
2019 Q1	$23.8M	Sell	268,082 -42,816	-14%	-$3.8M	0.02%	604
2018 Q4	$26.5M	Sell	310,898 -98,823	-24%	-$8.42M	0.03%	519
2018 Q3	$39.7M	Buy	409,721 +153,851	+60%	+$14.9M	0.04%	435
2018 Q2	$24.1M	Sell	255,870 -49,705	-16%	-$4.68M	0.02%	620
2018 Q1	$24.8M	Buy	305,575 +48,485	+19%	+$3.93M	0.02%	636
2017 Q4	$22.9M	Sell	257,090 -127,328	-33%	-$11.4M	0.02%	649
2017 Q3	$35.8M	Sell	384,418 -49,788	-11%	-$4.63M	0.03%	444
2017 Q2	$39.4M	Sell	434,206 -71,682	-14%	-$6.51M	0.04%	417
2017 Q1	$44.4M	Buy	505,888 +76,519	+18%	+$6.72M	0.04%	400
2016 Q4	$35.6M	Sell	429,369 -111,956	-21%	-$9.27M	0.04%	478
2016 Q3	$50.1M	Sell	541,325 -9,308	-2%	-$861K	0.05%	374
2016 Q2	$42.8M	Sell	550,633 -9,568	-2%	-$744K	0.05%	395
2016 Q1	$46.2M	Buy	560,201 +73,627	+15%	+$6.07M	0.06%	347
2015 Q4	$51M	Buy	486,574 +19,959	+4%	+$2.09M	0.06%	356
2015 Q3	$49.1M	Sell	466,615 -119,286	-20%	-$12.6M	0.06%	338
2015 Q2	$80.1M	Sell	585,901 -31,791	-5%	-$4.35M	0.08%	237
2015 Q1	$77M	Buy	617,692 +32,750	+6%	+$4.08M	0.08%	241
2014 Q4	$52.9M	Sell	584,942 -563,800	-49%	-$51M	0.05%	397
2014 Q3	$82.9M	Buy	1,148,742 +52,256	+5%	+$3.77M	0.07%	267
2014 Q2	$68.2M	Buy	1,096,486 +533,722	+95%	+$33.2M	0.06%	307
2014 Q1	$38.4M	Buy	562,764 +135,729	+32%	+$9.26M	0.04%	466
2013 Q4	$30M	Sell	427,035 -17,216	-4%	-$1.21M	0.03%	546
2013 Q3	$32.1M	Sell	444,251 -86,414	-16%	-$6.24M	0.03%	433
2013 Q2	$29.6M	Buy	+530,665	New	+$29.6M	0.03%	492